RESUMO
BACKGROUND: To quantify residual setup errors (RSE) and required planning target volumes (PTV) margins in head-and-neck cancer (HNC) radiotherapy when using daily image guidance (IG) and less-than-daily IG protocols. MATERIAL AND METHODS: Daily on-line kV-image registrations of 80 HNC patients (2640 imaged treatment fractions) were retrospectively studied to analyze RSE. Less-than-daily imaging protocols, using different action levels, were simulated on the data. To quantify local RSE; single rigid bony structures were defined as landmarks. The RSEs and required PTV margins were computed for each sub-structure with and without daily IG. RESULTS: For less-than-daily IG protocols the setup accuracy was more dependent on frequent imaging throughout the treatment course than the number of initially imaged fractions. With daily IG the RSE of the sub-structures ranged from 0.6 mm to 2.3 mm (systematic) and from 1.0 mm to 1.7 mm (random). Required PTV margins for the sub-regions ranged from 4.5 mm to 9.3 mm with no IG and from 2.3 mm to 6.8 mm with daily IG. CONCLUSION: Anatomical changes over the treatment course require frequent IG to achieve accurate dose delivery using highly conformal radiotherapy techniques. The current study shows that considerable local RSE may remain even with daily IGRT. The comprehension of local RSEs in HNC radiotherapy is important when designating PTV margins as well as tolerance levels for couch correction and plan adaption.
Assuntos
Neoplasias de Cabeça e Pescoço/radioterapia , Erros de Configuração em Radioterapia/estatística & dados numéricos , Radioterapia Conformacional/normas , Radioterapia Guiada por Imagem/normas , Humanos , Radioterapia Conformacional/métodos , Estudos RetrospectivosRESUMO
Background and purpose: Neoadjuvant short-course radiotherapy (SCRT) followed by full-dose systemic chemotherapy is an established treatment modality in locally advanced rectal cancer (LARC). Until recently, SCRT has been exclusively delivered with photons. Proton beam therapy (PBT) may minimize acute toxicity, which in turn likely impacts favorably on the tolerability to subsequent chemotherapy. The aim of this study is a dosimetric comparison between SCRT with photons and protons in the randomized phase II trial PRORECT (NCT04525989). Materials and methods: From June 2021 to June 2022, twenty consecutive patients with LARC have been treated according to study protocol. For each patient, both a VMAT and a PBT treatment plans have been generated and compared pairwise. Results: Dose-volume histogram (DVH) analysis revealed that SCRT with protons significantly reduced radiation dose to pelvic organs at risk including bladder, bones, and bowel in comparison to SCRT with photons. Photon and proton treatment plans had equivalent conformity and homogeneity indexes. Conclusion: Preoperative SCRT with protons offers a significant reduction of radiation dose to normal tissues compared with current photon-based radiotherapy technique. Demonstrated dosimetric advantages may translate into measurable clinical benefits in patients with LARC. Clinical implications of the dosimetric superiority of SCRT with protons will be presented in the coming reports from the PRORECT trial.
RESUMO
Image-guided radiation therapy (IGRT) can be used to measure and correct positional errors for target and critical structures immediately prior to or during treatment delivery. Some of the most recent available methods applied for target localization are: transabdominal ultrasound, implanted markers with in room MV or kV X-rays, optical surface tracking systems, implantable electromagnetic markers, in room CT such as kVCT on rail, kilovoltage or megavoltage cone-beam CT (CBCT) and helical megavoltage CT. The verification of the accurate treatment position in conjunction with detailed anatomical information before every fraction can be essential for the outcome of the treatment. In this paper we present the on-board imager (OBI, Varian Medical Systems, Palo Alto, CA) that has been in routine clinical use at the Karolinska University Hospital since June 2004. The OBI has been used for on-line set-up correction of prostate patients using internal gold markers. Displacements of these markers can be monitored radiographically during the treatment course and the registered marker shifts act as a surrogate for prostate motion. For this purpose, on-board kV-kV seems to be an ideal system in terms of image quality. The CBCT function of OBI was installed in March 2005 at our department. It focuses on localizing tumors based on internal anatomy, not just on the conventional external marks or tattoos. The CBCT system provides the capacity for soft tissue imaging in the treatment position and real-time radiographic monitoring during treatment delivery.